Type I interferon signaling promotes mucosal inflammation in murine models of colitis
This study demonstrates that Type I interferon signaling drives mucosal inflammation in inflammatory bowel disease by upregulating myeloid cell responses, as evidenced by elevated signatures in human patients and increased disease susceptibility in mice, while postnatal inhibition of this pathway offers protection against colitis.